These compounds may interact with:
Kallikrein-7
Potentially involved in: carcinoma; netherton syndrome; dermatitis; cancer; astrocytic glioma; breast cancer; ependymoma; esophageal adenocarcinoma; glioblastoma; oligodendroglioma; osteosarcoma; ovarian cancer; pancreatic cancer; psoriasis
Disease data sourced from Pharos.